Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease cystoid macular dystrophy
Comorbidity C0011884|diabetic retinopathy
Sentences 28
PubMedID- 24363502 Suggested that hba1c and total cholesterol are the two most important risk factors associated with clinically significant macular edema (csme) in patients with nonproliferative diabetic retinopathy [63] whereas zoppini et al.
PubMedID- 24959068 Background: this study evaluated the effect of intravitreal injection of bevacizumab (ivb) on macular edema associated with diabetic retinopathy (dme) or branch retinal vein occlusion (brvome) using laser speckle flowgraphy.
PubMedID- 24348012 Fundus examination of the right eye showed nonproliferative diabetic retinopathy with macular edema and a swollen optic disk.
PubMedID- 25613583 Twenty (40 %) patients had severe non-proliferative diabetic retinopathy with mild macular edema, which is the most prevalent type among the cases group.
PubMedID- 25636266 Triamcinolone acetonide (ta), as a long-term glucocorticoid, has been proved to be effective for treating macular edema associated with diabetic retinopathy (dr) and ischemic central retinal vein occlusion (crvo) [7, 8].
PubMedID- 26106919 We review developments in regenerative medicine (e.g., retinal prosthesis, optogenetics, cell-based therapy), diagnostics (e.g., swept source optical coherence tomography [oct], intraoperative oct, multimodal imaging), surgical innovations (e.g., chemical vitreolysis with ocriplasmin, 27-gauge vitrectomy), and pharmacological therapy of retinal vascular disease (e.g., use of ranibizumab and aflibercept in the treatment of macular edema associated with diabetic retinopathy and retinal vein occlusion).
PubMedID- 20534920 Two patients who had bcva < 20/200 had preexisting diabetic retinopathy with macular edema.
PubMedID- 22548042 Cystoid macular edema developed in a patient with diabetic retinopathy and neovascular glaucoma.
PubMedID- 24707168 Patients were divided into three groups: mild–moderate nonproliferative diabetic retinopathy without macular edema (npdr), mild–moderate nonproliferative diabetic retinopathy with macular edema (dme), and proliferative diabetic retinopathy (pdr).
PubMedID- 23961505 Fundus examination revealed bilateral severe proliferative diabetic retinopathy with macular edema and grade 2 hypertensive retinopathy.
PubMedID- 23792485 Purpose: to evaluate the predictive value of microaneurysm (ma) formation rate concerning the development of clinically significant macular edema (csme) in patients with mild-to-moderate nonproliferative diabetic retinopathy as evaluated by an automated analysis of central field fundus 30 degrees photographs.
PubMedID- 22937513 Aim: to determine the risk factors of clinically significant macular edema (csme) in patients with non-proliferative diabetic retinopathy (npdr) in a multi-ethnics malaysian population.
PubMedID- 22279402 Posterior segment examination [figures 1 and 2] showed mild nonproliferative diabetic retinopathy without diabetic macular edema and a normal looking optic disc od with a small cup-to-disc (cd) ratio (0.1).
PubMedID- 23204247 Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.
PubMedID- 20642348 Results: in type 1 diabetes patients we observed a prevalence of 36.47% of diabetic retinopathy and 5.73% with macular edema; in type 2 diabetes patients the prevalence of diabetic retinopathy was 26.11% and 6.44% with macular edema.
PubMedID- 21772983 The purpose of this study was to evaluate the effectiveness of intravitreal ranibizumab (lucentis, genentech, south san francisco, calif, usa) combined with cataract surgery for the prevention of clinically significant macular edema (csme) in patients with diabetic retinopathy (dr).
PubMedID- 26315560 One-year progression of diabetic subclinical macular edema in eyes with mild nonproliferative diabetic retinopathy: location of the increase in retinal thickness.
PubMedID- 20393241 Materials and methods: an observational case-study which included 180 type 2 diabetic patients (180 eyes) of nonproliferative diabetic retinopathy (npdr) with clinically significant macular edema (csme).
PubMedID- 23807186 Purpose: to evaluate whether intravitreal ranibizumab injection at cataract surgery prevents postoperative diabetic macular edema (pme) in patients with stable diabetic retinopathy without significant macular edema.
PubMedID- 24978668 Conclusion: we demonstrated a significantly reduced sensitivity in both nonproliferative diabetic retinopathy groups without diabetic macular edema compared with healthy controls; this reduction was greater in type 2 diabetic patients.
PubMedID- 22983424 In addition, it induces vascular hyperpermeability leading, for example, to central macular edema in patients with diabetic retinopathy [33] or retinal vein occlusion [34].
PubMedID- 25389718 Difluprednate ophthalmic emulsion 0.05% as adjunctive treatment to panretinal photocoagulation for proliferative diabetic retinopathy with clinically significant macular edema.
PubMedID- 22224029 The fundus exam showed severe bilateral nonproliferative diabetic retinopathy, with greater macular edema in the right eye compared to the left eye.
PubMedID- 20110406 Vision loss in diabetic retinopathy is due to macular edema characterized by increased vascular permeability, which involves phosphorylation associated with activation of protein kinase c (pkc) isoforms.
PubMedID- 24843311 All the patients had proliferative diabetic retinopathy with chronic macular edema.
PubMedID- 24707120 Diabetic eye disease with its complications, especially diabetic retinopathy that leads to macular edema and retinal neovascularization, is the leading cause of visual dysfunction and blindness among adult working-age population in economically developed societies worldwide.
PubMedID- 20936526 Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy.
PubMedID- 23258912 Relevant to the reduced risk of macular edema in diabetic retinopathy is the observation that fenofibrate inhibits endothelial cell layer permeability caused by oxygen-glucose deprivation in a pparα-dependent manner (11).

Page: 1